USFDA concludes inspection at Indoco Remedies’ Clinical Research Organization

22 Jul 2022 Evaluate

The United States Food and Drug Administration (USFDA) has successful concluded inspection at Indoco Remedies’ Clinical Research Organization – AnaCipher. The inspection conducted between July 11th- 15th, 2022. During the remote record review, the agency did not identify any objectionable conditions and thus, did not have any observations. This inspection was conducted by the Division of New Drug Study Integrity, Office of Study Integrity and Surveillance of USFDA. The scope of the inspection included Bioanalytical phase of multiple studies, of which one was ‘First to File’.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

210.20 -4.75 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×